David Luterman in Dallas, Texas

Home Texas Dallas

David Luterman has Pulmonary Disease as his primary medical specialty. Their primary office is: 3600 Gaston Ave in Dallas, Texas.

They're a part of the: Texas Lung Center, P.a. medical group which has around 2 members. You can call their office at 214-824-8521 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Texas Southwestern Medical School At Dallas and graduated in 1970 (around 54 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David L Luterman Office Phone and Directions

David Luterman
Texas Lung Center, P.a.
3600 Gaston Ave
Dallas, Texas 75246
214-824-8521

Patient Ratings
Please rate your experience with David Luterman below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 214-824-8521

Enter a starting address:

Healthcare Info for David Luterman

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: University Of Texas Southwestern Medical School At Dallas
Graduation Year: 1970
The Primary Medical Specialty for David Luterman is listed as: Pulmonary Disease
Approximate Years of Experience: 54
PAC (PECOS ID)#: 8224190160
NPI #: 1629079751
NPI Created On: 08/10/2005
NPI Last Updated Listed as: 02/06/2013
Primary Taxonomy Code: 207RP1001X
License Number:
D7162
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

X-ray of chest, 2 views
Hemoglobin measurement
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Measurement of inhaled nitric oxide gas
Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
Sleep monitoring of patient (6 years or older) in sleep lab
Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes
Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828523493

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: GIVLAARI

Open Associated Drug #1: 71336-1001-1

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801603215

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801930999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802438645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802483151

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802698033

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802795231

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802845093

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802873149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802917973

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Dallas

1.
Valentino Fernandes MD

221 W Colorado Blvd
Dallas, TX
Dallas Pulmonary And Critical Care, Pa

2.
Muhanned Abu-hijleh MD

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

3.
Muhanned Abu-hijleh MD

6201 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

4.
John Fitzgerald

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

5.
John Fitzgerald

5200 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

6.
John Fitzgerald

6201 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

Providers in Texas Lung Center, P.a.

1.David Luterman

3600 Gaston Ave
Dallas Tx 75246-1808
Texas Lung Center, P.a.
Pulmonary Disease

2.Joyce Shotwell Md

3600 Gaston Ave
Dallas Tx 75246-1808
Texas Lung Center, P.a.
Pulmonary Disease

View all 2 members of Texas Lung Center, P.a. medical group